Moreover, the European Leukemia Net (ELN) guidelines incorporated gene mutations including RUNX1 and TP53 for AML stratification, which underlined the importance of genetic mutations in disease prognosis [6]. This evidence concerns the gene RUNX1 and acute myeloid leukemia.